Luria Auditorium, Koch Institute (76-156)
500 Main Street, Cambridge, MA 02139
Multiplexed, High-Throughput Serum Assays Using Lentivirus Display to Analyze Antibody Responses
Antibodies are an integral part of our immune system. Whether generated through antigen exposure or provided as therapeutics, antibodies can direct targeted responses against specific antigens on foreign substances, pathogens, and cells. Therefore, accurately, efficiently, and comprehensively characterizing the antigen recognition capabilities of individuals’ antibody repertoires is critical to understanding individuals’ extent of protection against disease. As existing antibody measurement techniques are limited in their ability to test antibodies’ recognition of multiple, native-conformation antigens in a single reaction, we developed assays that employ libraries of hybrid pseudo-typed, DNA-barcoded lentiviruses to measure antibodies in a multiplexed, high-throughput manner. To record interactions between library lentiviruses and serum antibodies, our assays utilize cells expressing either an Fc receptor or viral entry receptor to measure antibodies’ binding or neutralization of their target antigens, respectively. During the COVID-19 pandemic, we constructed a lentivirus library with members displaying SARS-CoV-2 spike protein variants and other viral surface proteins to study the effects of infection, vaccination, and monoclonal antibody therapies on antiviral antibody responses. Using sera from pre-pandemic, COVID-19 convalescent, and COVID-19 vaccinated donors and validating our assays’ readouts against those from established immunoassays, we were able to demonstrate the ability of our assays to differentiate between samples with and without antibodies against antigens of interest. By engineering our lentiviruses to display additional antigens and cell lines to express other Fc and viral entry receptors, we can further enhance our ability to characterize how different diseases, and medical interventions impact the development and maintenance of targeted antibody responses.
Thesis Supervisor:
Michael Birnbaum, Ph.D.
Associate Professor of Biological Engineering, MIT
Thesis Committee Chair:
Douglas Lauffenburger, Ph.D.
Ford Professor of Engineering, MIT
Thesis Readers:
Facundo Batista, Ph.D.
Phillip T. and Susan M. Ragon Professor of Biology, MIT
Associate Director and Scientific Director of the Ragon Institute of MGH, MIT, and Harvard
Duane Wesemann, M.D., Ph.D.
Associate Professor of Medicine, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital
________________________________________________________________________________________
Zoom Invitation
Amanda Hornick is inviting you to a scheduled Zoom meeting
Topic: Amanda Hornick MEMP PhD Thesis Defense
Time: Monday, September 29, 2025, 9:30 AM Eastern Time (US and Canada)
Your participation is important to us: please notify hst [at] mit.edu (hst[at]mit[dot]edu), at least 3 business days in advance, if you require accommodations in order to access this event.
Join Zoom Meeting
Https://mit.zoom.us/j/99111887119
Password: 878771
One tap mobile
+16465588656,,99111887119# US (New York)
+16699006833,,99111887119# US (San Jose)
Meeting ID: 991 1188 7119
US: +1 646 558 8656 or +1 669 900 6833
International Numbers: https://mit.zoom.us/u/axqrYDiC3
Join by SIP
99111887119 [at] zoomcrc.com (99111887119[at]zoomcrc[dot]com)
Join by Skype for Business
https://mit.zoom.us/skype/99111887119